ABSI - Absci Corp
IEX Last Trade
4.41
0.110 2.494%
Share volume: 673,601
Last Updated: Fri 30 Aug 2024 09:59:57 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$4.30
0.11
2.56%
View ratios
Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
---|---|---|---|---|---|---|---|---|---|
Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
Report Date | 2022-08-11 | 2022-11-09 | 2023-03-30 | 2023-05-15 | 2023-08-14 | 2023-11-14 | 2024-03-21 | 2024-05-14 | |
Total revenue | 1.002 M | 2.369 M | 1.557 M | 1.269 M | 3.367 M | 744.000 K | 338.000 K | 898.000 K | |
Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
Gross profit | 1.002 M | 2.369 M | 1.557 M | 1.269 M | 3.367 M | 744.000 K | 338.000 K | 898.000 K | |
136.43% | -34.28% | -18.50% | 165.33% | -77.90% | -54.57% | 165.68% | |||
Operating expenses | 26.748 M | 26.932 M | 19.064 M | 22.250 M | 21.522 M | 20.534 M | 21.593 M | 20.980 M | |
Selling general and admin | 10.507 M | 11.407 M | 7.749 M | 9.593 M | 9.410 M | 9.505 M | 9.324 M | 8.744 M | |
Research and development | 16.241 M | 15.525 M | 11.315 M | 12.657 M | 12.112 M | 11.029 M | 12.269 M | 12.236 M | |
Total expenses | 29.889 M | 30.336 M | 22.650 M | 25.754 M | 25.020 M | 24.047 M | 25.077 M | 24.396 M | |
1.50% | -25.34% | 13.70% | -2.85% | -3.89% | 4.28% | -2.72% | |||
Operating income | -28.887 M | -27.967 M | -21.093 M | -24.485 M | -21.653 M | -23.303 M | -24.739 M | -23.498 M | |
Ebit | -28.887 M | -27.967 M | -21.093 M | -24.485 M | -21.653 M | -23.303 M | -24.739 M | -23.498 M | |
Pretax income | -28.950 M | -27.571 M | -19.971 M | -23.348 M | -41.661 M | -21.960 M | -23.497 M | -21.963 M | |
-4.76% | -27.57% | 16.91% | 78.43% | -47.29% | 7.00% | -6.53% | |||
Income tax | -270.000 K | -312.000 K | -500.000 K | 7.000 K | 11.000 K | 34.000 K | 48.000 K | 12.000 K | |
Net income basic | -28.680 M | -27.259 M | -19.471 M | -23.355 M | -41.672 M | -21.994 M | -23.545 M | -21.975 M | |
4.95% | 28.57% | -19.95% | -78.43% | 47.22% | -7.05% | 6.67% | |||
Net income | -28.680 M | -27.259 M | -19.471 M | -23.355 M | -41.672 M | -21.994 M | -23.545 M | -21.975 M | |
4.95% | 28.57% | -19.95% | -78.43% | 47.22% | -7.05% | 6.67% |